Andrea Ammon | |
---|---|
Director of the European Centre for Disease Prevention and Control | |
In office 1 May 2015 –15 June 2024 | |
Preceded by | Marc Sprenger |
Succeeded by | Pamela Rendi-Wagner |
Personal details | |
Born | 11 December 1958 |
Andrea Ammon (born 11 December 1958) is a German physician and the former director of the European Centre for Disease Prevention and Control (ECDC),a European Union (EU) agency strengthening Europe's defence against infectious disease. [1] She advised the German government on the SARS and Influenza A virus subtype H2N2 outbreaks.
In 1996 Ammon completed her doctorate in medicine at the Ludwig Maximilian University of Munich,where she studied the quality of life for patients that have palliative therapy for metastatic liver disease. [2]
Ammon joined the Robert Koch Institute in Berlin in 1996. Between 2002 and 2005,she was Head of Department for Infectious Disease Epidemiology. [3] At the Robert Koch Institute,Ammon was responsible for the German national outbreak surveillance system,coordinating their response to severe acute respiratory syndrome (SARS) and Influenza A virus subtype H2N2. [4] As part of this effort,Ammon investigated in-flight transmission of SARS and found that it was uncommon;and only likely if infected people fly during symptomatic phases of their illness. [5]
In 2005,Ammon joined the European Centre for Disease Prevention and Control (ECDC),where she was appointed Head of Surveillance. [1] [6] She was one of the first employees at the ECDC,and has since been described as "instrumental" in establishing the surveillance strategy. [3] The ECDC looks to standardise infection control across the European Union,ensuring consistent practise took place in the surveillance networks of member states. In this capacity she was responsible for the formation of The European Surveillance System (TESSy),a uniform,long-term data acquisition system for the European Union. [7] TESSy launched in April 2008. [7]
Ammon was responsible for evaluating the European Dedicated Surveillance Networks (DSN),which included the EURO TB and EURO HIV networks,eventually incorporating them into the framework of the ECDC. [8] In 2011 she was made deputy director of the Resource Management and Coordination unit. [9] A few years later,she led the European Scientific Conference on Applied Infectious Disease Epidemiology. [10] As part of the conference,in the wake of the Western African Ebola virus epidemic,Ammon oversaw sessions on food-borne diseases,zoonotic viruses and globalisation. [10] She succeeded Marc Sprenger as Acting Director of the ECDC on 1 May 2015. [11] She was subsequently appointed Director [12] on 22 March 2017 and took office on 16 June 2017. [13] [14] In 2017 the ECDC and WHO announced that whilst cases of tuberculosis were on the decline in Europe,tuberculosis in relation to HIV was on the rise. [15]
During the COVID-19 pandemic,Ammon was involved with the global response to the COVID-19 pandemic. On January 26,Ammon and the ECDC advised governments in the European Union to strengthen their healthcare capacity. [16] Unfortunately,the ECDC had over-estimated the stocks of personal protective equipment and lab testing capacity in individual member states,resulting in considerable spread of coronavirus disease across Europe. [17] She has since said that the extensive spread of coronavirus in Europe can be linked to the return of holidaymakers from skiing trips in early March. [16] In early May,Ammon gave evidence before the European Parliament on public health,and said that the United Kingdom was behind other European member states in their response to coronavirus disease. [18] In an interview with The Guardian on May 20,2020,Ammon emphasised that there was likely to be a second wave of SARS-CoV-2 infections,“...the question is when and how big.” [16]
In the preparations for the Global Health Summit hosted by the European Commission and the G20 in May 2021,Ammon was a member of the event's High Level Scientific Panel. [19]
Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B, viruses that cause the flu. Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. They recommend it to prevent infection in those at high risk, but not the general population. The Centers for Disease Control and Prevention (CDC) recommends that clinicians use their discretion to treat those at lower risk who present within 48 hours of first symptoms of infection. It is taken by mouth, either as a pill or liquid.
Tick-borne encephalitis (TBE) is a viral infectious disease involving the central nervous system. The disease most often manifests as meningitis, encephalitis or meningoencephalitis. Myelitis and spinal paralysis also occurs. In about one third of cases sequelae, predominantly cognitive dysfunction, persist for a year or more.
The European Centre for Disease Prevention and Control (ECDC) is an agency of the European Union (EU) whose mission is to strengthen Europe's defences against infectious diseases. It covers a wide spectrum of activities, such as: surveillance, epidemic intelligence, response, scientific advice, microbiology, preparedness, public health training, international relations, health communication, and the scientific journal Eurosurveillance. The centre was established in 2004 and is headquartered in Solna, Sweden.
The European Programme for Intervention Epidemiology Training (EPIET) Fellowship provides training and practical experience in intervention epidemiology at the national centres for surveillance and control of communicable diseases in the European Union. The fellowship is aimed at EU medical practitioners, public-health nurses, microbiologists, veterinarians and other health professionals with previous experience in public health and a keen interest in epidemiology.
Field Epidemiology is the application of epidemiologic methods to unexpected health problems when a rapid on-site investigation is necessary for timely intervention. A more expansive definition is: The practice of Epidemiology in the field. Work is done in communities often as a public health service and as part of government or a closely allied institution. Field epidemiology is how epidemics and outbreaks are investigated, and is used to implement measures to protect and improve the health of the public. Field epidemiologists must deal with unexpected, sometimes urgent problems that demand immediate solution. Its methods are designed to answer specific epidemiologic questions in order to plan, implement, and/or evaluate public health interventions. These studies consider the needs of those who will use the results. The task of a field epidemiologist is not complete until the results of a study have been clearly communicated in a timely manner to those who need to know, and an intervention made to improve the health of the people.
Eurosurveillance is an open-access medical journal covering epidemiology, surveillance, prevention, and control of communicable diseases with a focus on topics relevant for Europe. The journal is a non-profit publication and is published by the European Centre for Disease Prevention and Control.
The Centre for Disease Control and Prevention was created in 2001 and is under the Health Bureau of Secretariat for Social Affairs and Culture of Macau, China.
Middle East respiratory syndrome–related coronavirus (MERS-CoV), or EMC/2012 (HCoV-EMC/2012), is the virus that causes Middle East respiratory syndrome (MERS). It is a species of coronavirus which infects humans, bats, and camels. The infecting virus is an enveloped, positive-sense, single-stranded RNA virus which enters its host cell by binding to the DPP4 receptor. The species is a member of the genus Betacoronavirus and subgenus Merbecovirus.
London1_novel CoV/2012 is a coronavirus strain isolated from a Qatari man in London in 2012 who was one of the first patients to come down with what has since been named Middle East respiratory syndrome-related coronavirus (MERS-CoV). The Qatari patient had traveled to Saudi Arabia from Qatar. He returned to Qatar, but when he fell ill, he traveled to London for treatment. The United Kingdom's Health Protection Agency (HPA) named the virus.
Since 2012, an outbreak of Middle East respiratory syndrome coronavirus has affected several countries, primarily in its namesake, the Middle East. The virus, which causes Middle East respiratory syndrome (MERS), is a novel coronavirus that was first identified in a patient from Jeddah, Saudi Arabia on 6 June 2012.
The Health Protection Surveillance Centre (HPSC) is part of Ireland's Health Service Executive.
Coronavirus diseases are caused by viruses in the coronavirus subfamily, a group of related RNA viruses that cause diseases in mammals and birds. In humans and birds, the group of viruses cause respiratory tract infections that can range from mild to lethal. Mild illnesses in humans include some cases of the common cold, while more lethal varieties can cause SARS, MERS and COVID-19. As of 2021, 45 species are registered as coronaviruses, whilst 11 diseases have been identified, as listed below.
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019. Most scientists believe the SARS-CoV-2 virus entered into human populations through natural zoonosis, similar to the SARS-CoV-1 and MERS-CoV outbreaks, and consistent with other pandemics in human history. Social and environmental factors including climate change, natural ecosystem destruction and wildlife trade increased the likelihood of such zoonotic spillover. The disease quickly spread worldwide, resulting in the COVID-19 pandemic.
Dale Andrew Fisher FRACP is an infectious diseases physician who specialises in Infectious Diseases and a Senior Consultant in the Division of Infectious Diseases at the National University Hospital, Singapore. He is also a professor of medicine at the Yong Loo Lin School of Medicine, National University of Singapore, and the chair of the National Infection Prevention and Control Committee through the Ministry of Health, Singapore. In 2020, he became group chief of Medicine for National University Health Systems.
A patient under investigation refers to a person who had been in close contact with a person with confirmed infection or/and may have been to place where there is an outbreak or superspreading event. This person exhibits the symptoms of the disease and is required to be tested, and undergo a quarantine or isolation while waiting for the laboratory results. It is a term used by health care workers in classifying patients during evaluation and testing in contact tracing in times of infectious disease outbreaks.
COVID-19 surveillance involves monitoring the spread of the coronavirus disease in order to establish the patterns of disease progression. The World Health Organization (WHO) recommends active surveillance, with focus of case finding, testing and contact tracing in all transmission scenarios. COVID-19 surveillance is expected to monitor epidemiological trends, rapidly detect new cases, and based on this information, provide epidemiological information to conduct risk assessment and guide disease preparedness.
Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.
The transmission of COVID-19 is the passing of coronavirus disease 2019 from person to person. COVID-19 is mainly transmitted when people breathe in air contaminated by droplets/aerosols and small airborne particles containing the virus. Infected people exhale those particles as they breathe, talk, cough, sneeze, or sing. Transmission is more likely the closer people are. However, infection can occur over longer distances, particularly indoors.
West Nile Fever (WNF) is a mosquito-borne viral infection caused by the West Nile virus (WNV), a member of the Flaviviridae family. The virus primarily incubates in a bird-mosquito transmission cycle, with humans and other mammals serving as incidental hosts.